Pembrolizumab versus Ipilimumab in Advanced Melanoma
The anti-PD-1 antibody pembrolizumab prolonged progression-free survival and overall survival and had less high-grade toxicity than did ipilimumab in patients with advanced mela...
Explore 634 academic publications
The anti-PD-1 antibody pembrolizumab prolonged progression-free survival and overall survival and had less high-grade toxicity than did ipilimumab in patients with advanced mela...
Kristian Thygesen∗ (Denmark) Joseph S. Alpert∗ (USA) Allan S. Jaffe (USA) Bernard R. Chaitman (USA) Jeroen J. Bax (The Netherlands) David A. Morrow (USA) Harvey D. White∗ ...
The designations employed and the presentation of material in this information product do not imply the expression of any opinion whatsoever on the part of the Food and Agricult...
This paper outlines a new approach to the study of power, that of the sociology of translation. Starting from three principles, those of agnosticism (impartiality between actors...
This edition of Ronald Miller and Peter Blair's classic textbook is an essential reference for students and scholars in the input-output research and applications community. The...